Skip to main content


Fig. 2 | BMC Research Notes

Fig. 2

From: Prevalence and trends in transmitted and acquired antiretroviral drug resistance, Washington, DC, 1999–2014

Fig. 2

Most prevalent drug-resistant mutations for each analysis group by drug class, Washington DC, 1999–2014. NRTI, nucleoside/nucleotide analogue reverse transcriptase inhibitor (top 4); NNRTI, nonnucleoside reverse transcriptase inhibitor (top 4); PI, protease inhibitor (top 4); EI, entry/fusion inhibitor (top 2); INSTI, integrase strand transfer inhibitor (top 2)

Back to article page